Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study

OBJECTIVE: The aim of this randomized comparative study was to assess renal and metabolic effects of vildagliptin in insulin-treated type 2 diabetes (T2DM) patients without overt chronic kidney disease. SUBJECTS AND METHODS: We randomized 47 insulin-treated non-proteinuric patients with satisfactory...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayrasheva, Valentina K., Pchelin, Ivan Y., Dobronravov, Vladimir A., Babenko, Alina Yu., Chefu, Svetlana G., Shatalov, Ivan S., Vasilkova, Volha N., Hudiakova, Natalia V., Ivanova, Alexandra N., Andoskin, Pavel A., Grineva, Elena N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522081/
https://www.ncbi.nlm.nih.gov/pubmed/32267348
http://dx.doi.org/10.20945/2359-3997000000220

Ejemplares similares

Ejemplares similares